Return to PCORI.org 
Healthy Aging: Optimizing Physical and Mental Functioning Across the Aging Continuum – 2022 Cycle 3
- What intervention settings are allowable under this funding announcement?
- What is meant by an institutional setting?
- What do you mean by multisite?
- Are foreign institutions eligible to directly apply for funding?
- Do applicants need to confirm all study sites by the time of Letter of Intent (LOI) submission?
- Must all sites in a multisite study be identified by the time of application submission, or can they be identified later in the study?
- Which populations are this funding announcement targeting?
- Can studies have a focus on older adults with no chronic conditions?
- Are patients who are frail, but otherwise healthy, an eligible population?
- Are adults with intellectual, developmental, or other related disabilities an eligible population?
- How well-established should the intervention be?
- Does the proposed intervention need to be tested across the entire Aging Continuum?
- Do treatments and interventions need to be FDA approved?
- What types of study designs are ideal for these interventions?
- Are there particular interventions that are encouraged in the re-issuance of this PFA?
- Does this PFA allow pharmacologic interventions?
- Will PCORI be open to covering any intervention costs in the budget?
- Does PCORI provide support in finding patient advocates or groups?
- What is the required length of the LOI for this PFA?
- What is the maximum research project duration and the maximum project budget?